BRIEF-CEA Industries Continues Evaluation Of M&A Opportunities, Other Alternatives For Future Of Co-February 2024-www.financetom.com

BRIEF-CEA Industries Continues Evaluation Of M&A Opportunities, Other Alternatives For Future Of Co

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-CEA Industries Continues Evaluation Of M&A Opportunities, Other Alternatives For Future Of Co

Apr 10, 2024 3:23 PM

April 10 (Reuters) - CEA Industries Inc ( CEAD ):

* CEA INDUSTRIES ( CEAD ): CONTINUES TO EVALUATE MERGER AND

ACQUISITION

OPPORTUNITIES AND OTHER ALTERNATIVES FOR FUTURE OF CO

* CEA INDUSTRIES ( CEAD )- ON APRIL 9, GOT NOTICE FROM NASDAQ THAT

NASDAQ

WILL BE DELISTING SHARES OF COMMON STOCK & COMMON STOCK WARRANTS

ON APRIL 18

* CEA INDUSTRIES ( CEAD ): CONSIDERING LEGAL PROCEDURE AND PRACTICAL

STEPS

FOR DISSOLVING CO

Source text for Eikon:

Further company coverage:

Previous page： Apple set to sell Vision Pro headset outside US, Bloomberg News reports Next page： Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Apple set to sell Vision Pro headset outside US, Bloomberg News reports

May 13, 2024

May 13 (Reuters) - Apple ( AAPL ) is gearing up to sell its Vision Pro mixed-reality headset outside the United States, Bloomberg News reported on Monday, in a bid to invigorate demand for its most expensive bet in years. The iPhone-maker has flown hundreds of employees from its international stores to Cupertino, California and started training them on how...

Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4

May 13, 2024

12:59 PM EDT, 05/13/2024 (MT Newswires) -- Jasper Therapeutics ( JSPR ) said Monday it is expanding the company's mast cell development portfolio and will evaluate briquilimab, a conditioning agent for patients undergoing stem cell transplant, in patients with asthma in phase 1b/2a study. Enrolling in the study is expected to start in Q4, according to the company. We plan...

Market Chatter: Tesla Rehires Some People Dismissed From Supercharging Team

May 13, 2024

01:00 PM EDT, 05/13/2024 (MT Newswires) -- Tesla (TSLA) started rehiring some of the 500 workers from the supercharging team that Chief Executive Officer Elon Musk dismissed last month, Bloomberg reported, citing people familiar with the situation. Max de Zegher, formerly the director of charging for North America, was rehired, Bloomberg said. The exact number of rehired workers wasn't immediately...

Is Roaring Kitty Back For Round 2? GameStop Posts Flood WallStreetBets As Traders Eye Massive Gains: 'We Are So Back'

May 13, 2024

Support for GameStop Corp ( GME ) stock is still incredibly strong, as evidenced by the remarkable surge in the stock on Monday following a meme posted by the man who’s often credited with kicking off the meme stock mania of 2021. Here’s a look at what retail is saying about a potential round two. What To Know: Keith Gill, best...